The Safety and Efficacy of Supraglottic Airway Use in Children

Ann & Robert H Lurie Children's Hospital of Chicago

Status: Unknown

Conditions: Supraglottic Airway Use in Children

Treatments: Device: Supraglottic Airway Device

Study type: Observational

Funder types: Other

Identifiers

NCT02202174

2014-15832

Details and patient eligibility

About

This purpose of this study is to determine the effectiveness, risk factors, and complications associated with use of supraglottic airway devices for primary airway maintenance during routine anesthesia in children.

Full description

This study aims to understand the efficacy of supraglottic airway (SGA) use in children in a tertiary care Children's Hospital.

Observational data regarding the type of SGA, experience level of practitioner, placement technique, number of placement attempts or placement failure, device failure, and cause of any related peri-operative complications will be prospectively collected.

The data collected in this study will allow the investigators to assess the overall safety and efficacy of SGA use in various medical and surgical procedures performed under general anesthesia in children.

Enrollment: 10,000 estimated patients

Sex: All

Ages: 1 day to 18 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Children undergoing anesthesia with use of a supraglottic airway device as a primary means of oxygenation & ventilation

Exclusion criteria

• N/A

Trial design

10,000 participants in 1 patient group

Supraglottic Airway Device

Description:

Patients will receive a supraglottic airway device as a primary means of ventilation. The following devices may be used: LMA Unique, LMA ProSeal, LMA Supreme, LMA Flexible, Ambu Aura-I, Ambu Aura Once, Air-Q, I-Gel, or other supraglottic airway device. Choice of the device will be clinician dependent and based on the patients body weight per manufacturer guidelines

Treatment:

Device: Supraglottic Airway Device